In a bronchial biopsy cohort (20 controls, 94 GOLD0, 83 COPD), IL6‐AS1 expression peaked in GOLD3–4 patients (Figure 1L) and was highest in the clinical decline subgroup (Figure 1M). This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.